Cervical dystonia: clinical and therapeutic features in 85 patients

We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had h...

Full description

Saved in:
Bibliographic Details
Published in:Arquivos de neuro-psiquiatria 2008-03, Vol.66 (1), p.15-21
Main Authors: Camargo, Carlos Henrique F, Teive, Hélio A G, Becker, Nilson, Baran, Maria Helena Herdoíza, Scola, Rosana Hermínia, Werneck, Lineu César
Format: Article
Language:eng ; por
Subjects:
Adolescent
Adult
Aged
Botulinum Toxins, Type A - adverse effects
Botulinum Toxins, Type A - therapeutic use
Child
Child, Preschool
Electromyography
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neuromuscular Agents - adverse effects
Neuromuscular Agents - therapeutic use
NEUROSCIENCES
Pain Measurement
PSYCHIATRY
Severity of Illness Index
Torticollis - drug therapy
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3
cites cdi_FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3
container_end_page 21
container_issue 1
container_start_page 15
container_title Arquivos de neuro-psiquiatria
container_volume 66
creator Camargo, Carlos Henrique F
Teive, Hélio A G
Becker, Nilson
Baran, Maria Helena Herdoíza
Scola, Rosana Hermínia
Werneck, Lineu César
description We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p
doi_str_mv 10.1590/s0004-282x2008000100005
format article
fullrecord <record><control><sourceid>proquest_sciel</sourceid><recordid>TN_cdi_scielo_journals_S0004_282X2008000100005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S0004_282X2008000100005</scielo_id><sourcerecordid>20108067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3</originalsourceid><addsrcrecordid>eNp9UE1LxDAQDaK46-pf0J68dU3SjyTepPgFggcVvIVpmmCWbluTVNx_b-quiBcPwzAz783jPYTOCF6SQuALjzHOU8rpJ8WYx4HEwsUempOS8TSnlO2j-Q_odYaOvF9hTHMh2CGaEZ4JmmM2R1Wl3YdV0CbNxoe-s3CZqNZ23yvomiS8aQeDHoNVidEQRqd9YruEF8kAweou-GN0YKD1-mTXF-jl5vq5uksfHm_vq6uHVOWiDGnOteINhcJoUhhDuBAUyqameQk11MqweOO1ophlzNSlMAqass4ieTpBtkDL7V-vrG57uepH10VB-TQZlZPRP2lEwvmWMLj-fdQ-yLX1SrctdLofvaQRyHHJIpBtgcr13jtt5ODsGtxGEiynwP-RON1JjPVaN7-8XcLZF8Nbecs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20108067</pqid></control><display><type>article</type><title>Cervical dystonia: clinical and therapeutic features in 85 patients</title><source>SciELO Brazil</source><creator>Camargo, Carlos Henrique F ; Teive, Hélio A G ; Becker, Nilson ; Baran, Maria Helena Herdoíza ; Scola, Rosana Hermínia ; Werneck, Lineu César</creator><creatorcontrib>Camargo, Carlos Henrique F ; Teive, Hélio A G ; Becker, Nilson ; Baran, Maria Helena Herdoíza ; Scola, Rosana Hermínia ; Werneck, Lineu César</creatorcontrib><description>We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p&lt;0.0003). The severity of the abnormal head-neck movements were more severe among the patients with generalized dystonia (p&lt;0.001). Pain in the cervical area was noted in 59 patients. It was not possible to determine the etiology of the disease in 62.3% of patients. Tardive dystonia was the most common secondary etiology. A major improvement in the motor symptoms of CD and pain was observed in patients following treatment with BoNT/A. The tardive dystonia subgroup did not respond to the treatment. Dysphagia was observed in 2.35% of the patients.</description><identifier>ISSN: 0004-282X</identifier><identifier>ISSN: 1678-4227</identifier><identifier>EISSN: 1678-4227</identifier><identifier>EISSN: 0004-282X</identifier><identifier>DOI: 10.1590/s0004-282x2008000100005</identifier><identifier>PMID: 18392407</identifier><language>eng ; por</language><publisher>Brazil: Academia Brasileira de Neurologia - ABNEURO</publisher><subject>Adolescent ; Adult ; Aged ; Botulinum Toxins, Type A - adverse effects ; Botulinum Toxins, Type A - therapeutic use ; Child ; Child, Preschool ; Electromyography ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neuromuscular Agents - adverse effects ; Neuromuscular Agents - therapeutic use ; NEUROSCIENCES ; Pain Measurement ; PSYCHIATRY ; Severity of Illness Index ; Torticollis - drug therapy ; Treatment Outcome ; Young Adult</subject><ispartof>Arquivos de neuro-psiquiatria, 2008-03, Vol.66 (1), p.15-21</ispartof><rights>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3</citedby><cites>FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,24178,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18392407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Camargo, Carlos Henrique F</creatorcontrib><creatorcontrib>Teive, Hélio A G</creatorcontrib><creatorcontrib>Becker, Nilson</creatorcontrib><creatorcontrib>Baran, Maria Helena Herdoíza</creatorcontrib><creatorcontrib>Scola, Rosana Hermínia</creatorcontrib><creatorcontrib>Werneck, Lineu César</creatorcontrib><title>Cervical dystonia: clinical and therapeutic features in 85 patients</title><title>Arquivos de neuro-psiquiatria</title><addtitle>Arq Neuropsiquiatr</addtitle><description>We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p&lt;0.0003). The severity of the abnormal head-neck movements were more severe among the patients with generalized dystonia (p&lt;0.001). Pain in the cervical area was noted in 59 patients. It was not possible to determine the etiology of the disease in 62.3% of patients. Tardive dystonia was the most common secondary etiology. A major improvement in the motor symptoms of CD and pain was observed in patients following treatment with BoNT/A. The tardive dystonia subgroup did not respond to the treatment. Dysphagia was observed in 2.35% of the patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Botulinum Toxins, Type A - adverse effects</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Electromyography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuromuscular Agents - adverse effects</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>NEUROSCIENCES</subject><subject>Pain Measurement</subject><subject>PSYCHIATRY</subject><subject>Severity of Illness Index</subject><subject>Torticollis - drug therapy</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0004-282X</issn><issn>1678-4227</issn><issn>1678-4227</issn><issn>0004-282X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9UE1LxDAQDaK46-pf0J68dU3SjyTepPgFggcVvIVpmmCWbluTVNx_b-quiBcPwzAz783jPYTOCF6SQuALjzHOU8rpJ8WYx4HEwsUempOS8TSnlO2j-Q_odYaOvF9hTHMh2CGaEZ4JmmM2R1Wl3YdV0CbNxoe-s3CZqNZ23yvomiS8aQeDHoNVidEQRqd9YruEF8kAweou-GN0YKD1-mTXF-jl5vq5uksfHm_vq6uHVOWiDGnOteINhcJoUhhDuBAUyqameQk11MqweOO1ophlzNSlMAqass4ieTpBtkDL7V-vrG57uepH10VB-TQZlZPRP2lEwvmWMLj-fdQ-yLX1SrctdLofvaQRyHHJIpBtgcr13jtt5ODsGtxGEiynwP-RON1JjPVaN7-8XcLZF8Nbecs</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Camargo, Carlos Henrique F</creator><creator>Teive, Hélio A G</creator><creator>Becker, Nilson</creator><creator>Baran, Maria Helena Herdoíza</creator><creator>Scola, Rosana Hermínia</creator><creator>Werneck, Lineu César</creator><general>Academia Brasileira de Neurologia - ABNEURO</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>GPN</scope></search><sort><creationdate>20080301</creationdate><title>Cervical dystonia: clinical and therapeutic features in 85 patients</title><author>Camargo, Carlos Henrique F ; Teive, Hélio A G ; Becker, Nilson ; Baran, Maria Helena Herdoíza ; Scola, Rosana Hermínia ; Werneck, Lineu César</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; por</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Botulinum Toxins, Type A - adverse effects</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Electromyography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuromuscular Agents - adverse effects</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>NEUROSCIENCES</topic><topic>Pain Measurement</topic><topic>PSYCHIATRY</topic><topic>Severity of Illness Index</topic><topic>Torticollis - drug therapy</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Camargo, Carlos Henrique F</creatorcontrib><creatorcontrib>Teive, Hélio A G</creatorcontrib><creatorcontrib>Becker, Nilson</creatorcontrib><creatorcontrib>Baran, Maria Helena Herdoíza</creatorcontrib><creatorcontrib>Scola, Rosana Hermínia</creatorcontrib><creatorcontrib>Werneck, Lineu César</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>SciELO</collection><jtitle>Arquivos de neuro-psiquiatria</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Camargo, Carlos Henrique F</au><au>Teive, Hélio A G</au><au>Becker, Nilson</au><au>Baran, Maria Helena Herdoíza</au><au>Scola, Rosana Hermínia</au><au>Werneck, Lineu César</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cervical dystonia: clinical and therapeutic features in 85 patients</atitle><jtitle>Arquivos de neuro-psiquiatria</jtitle><addtitle>Arq Neuropsiquiatr</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>66</volume><issue>1</issue><spage>15</spage><epage>21</epage><pages>15-21</pages><issn>0004-282X</issn><issn>1678-4227</issn><eissn>1678-4227</eissn><eissn>0004-282X</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p&lt;0.0003). The severity of the abnormal head-neck movements were more severe among the patients with generalized dystonia (p&lt;0.001). Pain in the cervical area was noted in 59 patients. It was not possible to determine the etiology of the disease in 62.3% of patients. Tardive dystonia was the most common secondary etiology. A major improvement in the motor symptoms of CD and pain was observed in patients following treatment with BoNT/A. The tardive dystonia subgroup did not respond to the treatment. Dysphagia was observed in 2.35% of the patients.</abstract><cop>Brazil</cop><pub>Academia Brasileira de Neurologia - ABNEURO</pub><pmid>18392407</pmid><doi>10.1590/s0004-282x2008000100005</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0004-282X
ispartof Arquivos de neuro-psiquiatria, 2008-03, Vol.66 (1), p.15-21
issn 0004-282X
1678-4227
1678-4227
0004-282X
language eng ; por
recordid cdi_scielo_journals_S0004_282X2008000100005
source SciELO Brazil
subjects Adolescent
Adult
Aged
Botulinum Toxins, Type A - adverse effects
Botulinum Toxins, Type A - therapeutic use
Child
Child, Preschool
Electromyography
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neuromuscular Agents - adverse effects
Neuromuscular Agents - therapeutic use
NEUROSCIENCES
Pain Measurement
PSYCHIATRY
Severity of Illness Index
Torticollis - drug therapy
Treatment Outcome
Young Adult
title Cervical dystonia: clinical and therapeutic features in 85 patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T10%3A32%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sciel&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cervical%20dystonia:%20clinical%20and%20therapeutic%20features%20in%2085%20patients&rft.jtitle=Arquivos%20de%20neuro-psiquiatria&rft.au=Camargo,%20Carlos%20Henrique%20F&rft.date=2008-03-01&rft.volume=66&rft.issue=1&rft.spage=15&rft.epage=21&rft.pages=15-21&rft.issn=0004-282X&rft.eissn=1678-4227&rft_id=info:doi/10.1590/s0004-282x2008000100005&rft_dat=%3Cproquest_sciel%3E20108067%3C/proquest_sciel%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c496t-48ec8d2a5fe15ff18992a6db246ababcf72a58bc20737fb69fcad6b3496f72aa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20108067&rft_id=info:pmid/18392407&rft_scielo_id=S0004_282X2008000100005&rfr_iscdi=true